Their findings suggest that iCAFs may interact with NSCLC cells by activating molecules associated with invasion and metastasis, such as MET-hepatocyte growth factor (HGF) signaling pathway, thereby promoting brain metastasis in NSCLC [86]. The gene discussed is HGF; the disease is non-small cell lung carcinoma.